Masimo recently announced the recall of some of its Rad-G pulse oximeters after reports of unintended change of device power state. Nabbing FDA clearance in September 2020, Rad-G is a portable SET ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

“According to Masimo, the CBP ‘inexplicably reversed course’ from its prior rulings in finding that Apple could overcome the LEO by shipping its smartwatches separately from iPhones.” On Wednesday, ...

The latest legal dispute between Apple and pulse oximetry company Masimo today ended in a mistrial, reports Bloomberg. The jury overseeing the case was not able to come to a final decision in its ...

Masimo found out about restoration of pulse oximetry to the Apple Watch the same way that the rest of the world did, and is suing US Customs and Border Protection to stop the process. It seems Apple ...

The International Trade Commission (ITC) has backed medical firm Masimo in its case alleging patent infringement in the blood oxygen sensors of the Apple Watch. The number of specific patents ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...

Last week, when Apple announced the release of a “redesigned Blood Oxygen feature” to the Apple Watch, many figured Masimo (who had been suing Apple over patents related to the feature), would look ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...